These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3175314)

  • 81. The value of small clinical trials.
    MacRae KD
    Recent Results Cancer Res; 1988; 111():191-4. PubMed ID: 3051228
    [No Abstract]   [Full Text] [Related]  

  • 82. The use of data bases and historical controls in treatment comparisons.
    Byar DP
    Recent Results Cancer Res; 1988; 111():95-8. PubMed ID: 3175313
    [No Abstract]   [Full Text] [Related]  

  • 83. Statistics in nonrandomized studies.
    Rothman KJ
    Epidemiology; 1990 Nov; 1(6):417-8. PubMed ID: 2090277
    [No Abstract]   [Full Text] [Related]  

  • 84. Treatment by protocol: assessment of gains and losses.
    Scheurlen H
    Recent Results Cancer Res; 1988; 111():87-94. PubMed ID: 3051233
    [No Abstract]   [Full Text] [Related]  

  • 85. [Statistically significant--also relevant for the patient?].
    Lange S
    Med Klin (Munich); 1999 Apr; 94 Suppl 2():22-4. PubMed ID: 10740398
    [No Abstract]   [Full Text] [Related]  

  • 86. [Meta-analysis in epidemiology (1): the general characteristics].
    Delgado Rodríguez M; Sillero Arenas M; Gálvez Vargas R
    Gac Sanit; 1991; 5(27):265-72. PubMed ID: 1806526
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interpretation of random effects meta-analyses.
    Riley RD; Higgins JP; Deeks JJ
    BMJ; 2011 Feb; 342():d549. PubMed ID: 21310794
    [No Abstract]   [Full Text] [Related]  

  • 88. [Surviving is not equal to survival?].
    Martus P
    Med Klin (Munich); 1999 Apr; 94 Suppl 2():10-3. PubMed ID: 10740394
    [No Abstract]   [Full Text] [Related]  

  • 89. Prediction interval in random-effects meta-analysis.
    Spineli LM; Pandis N
    Am J Orthod Dentofacial Orthop; 2020 Apr; 157(4):586-588. PubMed ID: 32241366
    [No Abstract]   [Full Text] [Related]  

  • 90. Re: Is the Risk Difference Really a More Heterogeneous Measure?
    Schmidt AF; Dudbridge F; Groenwold RH
    Epidemiology; 2016 May; 27(3):e12. PubMed ID: 26808601
    [No Abstract]   [Full Text] [Related]  

  • 91. Clinical trials information monologues transform to dialogues.
    Carlsson C; Nilbert M
    Acta Oncol; 2007; 46(1):8-9. PubMed ID: 17438700
    [No Abstract]   [Full Text] [Related]  

  • 92. Meta-analysis of stress-related factors in cancer.
    Coyne JC; Ranchor AV; Palmer SC
    Nat Rev Clin Oncol; 2010 May; 7(5):. PubMed ID: 20432531
    [No Abstract]   [Full Text] [Related]  

  • 93. Clinical trials for clinicians.
    Gelber RD; Goldhirsch A
    Chest; 1989 Jul; 96(1 Suppl):97S-101S. PubMed ID: 2737006
    [No Abstract]   [Full Text] [Related]  

  • 94. Quo vadis meta-analysis? A potentially dangerous tool if used without adequate rules.
    Michels KB
    Important Adv Oncol; 1992; ():243-8. PubMed ID: 1582676
    [No Abstract]   [Full Text] [Related]  

  • 95. Limitations and advantages of meta-analysis in clinical trials.
    Rockette HE; Redmond CK
    Recent Results Cancer Res; 1988; 111():99-104. PubMed ID: 3175314
    [No Abstract]   [Full Text] [Related]  

  • 96. Some comments on meta-analysis: discussion of "issues specific to evaluation of studies of periodontitis".
    Kent R
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):445-7. PubMed ID: 1507034
    [No Abstract]   [Full Text] [Related]  

  • 97. Meta-analysis: weighing the evidence.
    Jones DR
    Stat Med; 1995 Jan; 14(2):137-49. PubMed ID: 7754262
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.